A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy.
Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
17 authors.
Carlien A M BennebroekDepartment of Ophthalmology, Amsterdam UMC, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.ORCID 0000-0002-4733-2120
Judith van ZwolDepartment of Ophthalmology, Amsterdam UMC, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.
Maartje C Montauban van SwijndregtDepartment of Ophthalmology, Amsterdam UMC, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.
Giorgio L PorroDepartment of Ophthalmology, Utrecht UMC, 3584 CX Utrecht, The Netherlands.
Rianne OostenbrinkENCORE-NF1 Center, Department of General Pediatrics, Erasmus MC, 3015 GD Rotterdam, The Netherlands.ORCID 0000-0001-7919-8934
Anne T M DittrichDepartment of Pediatrics, Radboud University Medical Center, Amalia Children's Hospital, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0002-7722-4585
Jan W PottDepartment of Ophthalmology, University Medical Center Groningen, University of Groningen, 9712 CP Groningen, The Netherlands.
Lisethe MeijerDepartment of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-3027-2758
Etienne J M JanssenDepartment of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.ORCID 0009-0005-4389-6040
Sylvia KlinkenbergDepartment of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.
Noel J BauerDepartment of Ophthalmology, Maastricht University Medical Center, 6229 HX Maastricht, The Netherlands.ORCID 0000-0003-0044-4405
Irene C NottingDepartment of Ophthalmology, Leids University Medical Center, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-3625-0752
Maria M van GenderenDepartment of Ophthalmology, Utrecht UMC, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-9286-8397
Michael W TanckDepartment of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.ORCID 0000-0001-9828-4459
Pim de GraafDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0003-1938-0747
Peerooz SaeedDepartment of Ophthalmology, Amsterdam UMC, University of Amsterdam, 1012 WP Amsterdam, The Netherlands.
Antoinette Y N Schouten-van MeeterenDepartment of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.ORCID 0000-0002-1089-8091
Funding
ODAS Stichting 2019-01
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
chemotherapychildlow-grade gliomaneurofibromatosis type 1optic pathway gliomaprognostic factorprogressionradiotherapysurvivalsystemic anticancer therapy
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A Retrospective, Nationwide, Multicenter Study on Diagnosis and Treatment Outcome of Pediatric Optic Pathway/Hypothalamic Gliomas Including Analysis of Risk Factors for Progression After Systemic Anticancer Therapy. · full record | OpenQuestion